Citius Pharmaceuticals, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Citius Pharmaceuticals, Inc. (CTXR) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $9.50 per share for the 3-month period ending 2024-12-31, per its 10-Q filed 2025-02-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-02-14
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-12-31 was $9.50, a 1257.14% increase year-over-year.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-12-31 was $0.70, a 44.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-12-31 was $1.25.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $17.50, a 1288.89% increase from fiscal 2023.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.26, a 36.04% decline from fiscal 2022.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $1.97.
- Citius Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2008 was $1.57.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $9.50 10-Q · filed 2025-02-14 | |||
| 2024-09-30 | $17.50 10-K · filed 2024-12-27 | |||
| 2024-06-30 | $0.70 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | $0.70 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $0.70 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | $1.26 10-K · filed 2023-12-29 | |||
| 2023-06-30 | $1.26 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $1.26 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $1.25 10-Q · filed 2023-02-10 | |||
| 2022-09-30 | $1.97 10-K · filed 2022-12-22 | |||
| 2022-06-30 | $1.97 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $1.98 10-Q · filed 2022-05-12 | |||
| 2021-09-30 | $2.03 10-Q · filed 2022-02-10 | |||
| 2014-09-30 | $0.45 10-K · filed 2015-12-14 | |||
| 2008-12-31 | $1.57 10-K · filed 2021-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |